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Background/Aims. Vitamin D3 is liposoluble, so dietary fat could increase its oral absorption. Our aim was to compare serum
25-hydroxyvitamin D [25(OH)D] after the oral intake of cholecalciferol with a high- or low-fat meal. Methods. In a single-blind,
parallel clinical trial, 32 healthy physicians were divided into two groups. In the same day, they ingested 50,000IU (1.25mg)
of vitamin D3 with food: group 1 (G1): lipids: 25.6g and group 2 (G2) lipids: 1.7g. Serum 25(OH)D (0, 7, and 14 days), and
parathyroid hormone (PTH), and calcium (0 and 14 days) were measured. Results. Baseline mean serum 25(OH)D levels were
42.7 ±19.0nmol/L in G1 and 36.4 ±19.0nmol/L in G2 (P = 0.38). After cholecalciferol, mean serum 25(OH)D was higher in G1
(P<0.001): 7 days: G1 = 46.2 (38.4–53.9)nmol/L and G2 = 33.7 (25.4–40.1)nmol/L; 14 days: G1 = 53.7 (45.2–62.1)nmol/L and
G2 = 33.7 (25.2–42.2)nmol/L. Serum PTH and 25(OH)D were negatively correlated before and after the intake of vitamin D3,
respectively, r =− 0.42 (P = 0.02) and r =− 0.52 (P = 0.003). Conclusions. A high-fat meal increased the absorption of vitamin
D3, as measured by serum 25(OH)D.
1.Introduction
Vitamin D is important for human health [1], and lower
serum 25-hydroxyvitamin D [25(OH)D] has been associated
with increased mortality [2]. Moreover, a high prevalence of
vitamin D deﬁciency has been identiﬁed worldwide in recent
years [3].Dietarysupplementsareusefultopreventandtreat
this deﬁciency [4].
As vitamin D is liposoluble, its oral absorption could
increase if ingested with a fat-rich meal. Although there are
several studies about the eﬀect of diﬀerent ways to supply
vitamin D in its serum levels [5–9] or in serum 25(OH)D
levels [10–14], only a few of these studies describe the
amount of fat ingested with vitamin D [7, 9, 11]. Therefore,
the aim of this study was to compare serum 25(OH)D levels
after the oral intake of cholecalciferol with a high- or low-fat
meal in young adults.
2.MaterialsandMethods
This single-blind parallel randomized trial included 32
healthy resident physicians in Porto Alegre, latitude 30◦,
Brazil. Height and weight were measured to calculate body
mass index (BMI: weight (kg)/height2 (m)). Two diﬀerent
groups were formed with 16 individuals, each according to
sexandBMI,andrandomlyassignedtoahigh-(Group1:G1)
o rl o w - f a tm e a l( G r o u p2 :G 2 ) .T h ee x c l u s i o nc r i t e r i aw e r e
not drinking milk; BMI ≥30kg/m2 or <18.5kg/m2; known
liver, kidney or endocrine disease; use of supplements of cal-
cium and/or vitamin D; use of anticonvulsants, barbiturates,
or glucocorticoids, and travel outside the Brazilian South
region during the previous 120 days. Skin phototype was
evaluated according to Fitzpatrick [15].
The low-fat meal contained skim milk, white bread with
fruit jelly, and fruit salad. The high-fat meal contained2 International Journal of Endocrinology
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Figure 1: Flow diagram of the participants. Abbreviation: BMI-Weight (kg)/Height (m)2.
Table 1: Nutritional composition of meals.1
Nutrients2 Group 1 Group 2
Lipids (%) 25.6g (48.7) 1.7g (3.3)
Carbohydrates (%) 43.3g (36.6) 95.5g (82.2)
Proteins (%) 17.2g (14.5) 16.8g (14.4)
Fiber 1,5g 3,5g
Energy 473kcal 465kcal
1According to the Brazilian Table of Food Composition [16].
2Percentage of total calories in the meal.
whole milk, white bread with bologna, and vegetable oil
margarine.
All participants came to the research unit on the same
day at 7:00AM, after overnight fasting. A blood sample
was collected to measure 25(OH)D, parathyroid hormone
(PTH), total calcium, albumin, magnesium, and creatinine,
and a urine sample was collected to measure creatinine,
calcium, and magnesium. Then, 50,000IU of cholecalciferol
in a capsule were administered by the oral route to each
subjectduringamealwithhigh-orlow-fatcontent(Table 1).
The subjects ingested the whole content of the meal, and
then were advised to avoid sun exposure and changes in their
usual eating pattern for the next two weeks. The researchers
who collected the samples were blinded to the groups.
Overnight fasting blood samples were collected after
7 days for measurement of 25(OH)D and 14 days for
measurement of 25(OH)D, PTH, and total calcium. Serum
was kept at −70◦C until the assay of 25(OH)D and PTH. All
samples were analyzed in the same run: 25(OH)D by chemi-
luminescence(LIAISON,DiaSorinInc.,Stillwater/MN,USA,
intra-assay coeﬃcient of variation = 5.5%) and PTH by
electrochemiluminescence (Roche Diagnostics, Indianapo-
lis/IN, USA, intra-assay coeﬃcient of variation = 2.8%).
The number of subjects, calculated to detect a 30%
diﬀerence in mean serum 25(OH)D levels between groups,
with a standard deviation of 7.7ng/mL [17], power of 80%,
and P<0.05, was 15 per group. One additional subject was
included in each group to allow for losses.
Repeated measures ANOVA was used to compare mean
serum 25(OH)D levels. Correlations were analyzed by the
Pearson correlation coeﬃcient. All data were analyzed with
SPSSv.16.0, and diﬀerences were considered signiﬁcant when
P<0.05.
Cholecalciferol in powder (Taizhou Hisound Chemical
Co. Ltd, Taizhou, Zhejiang, China) was provided by DEG
Ativando Princ´ ıpios Company, S˜ ao Paulo, SP, Brazil, which
evaluated its content through HPLC (99.9%). The content
of vitamin D3 in the capsules ranged from 48,170–52,777IU.
All of the vitamin D capsules contained lactose (82mg) and
crystalline micro cellulose (18mg). One International Unit
(1IU) of vitamin D is equal to 0.025 micrograms.
The study was approved by the Ethics Committee
of HCPA, and participants were included after written
informed consent.
3. Results
Forty resident physicians were invited to participate, and all
agreed. Seven were excluded because they had traveled to
regionswithhighUVBincidenceinthelast120days,andone
was excluded for having BMI >30kg/m2. Two participants,
one from each group, did not enter the protocol, for missing
the ﬁrst appointment: one forgot and the other was acutely
ill. All others were included in the analyses (Figure 1). The
study was conducted in October 2009.International Journal of Endocrinology 3
Table 2: Baseline characteristics of the study groups.
Parameters Normal Range Group 1 (n = 15) Group 2 (n = 15)
Males/females (n)6 /96 /9
Age (yr) 27.5 ±2.02 6 .7 ±1.7
BMI (kg/m2)2 2 .3 ±2.82 2 .5 ±2.6
Serum
25(OH)D (nmol/L) 42,7 ±19,0 36,4 ±19,0
PTH (ng/L) 14.0–72.0 34.9 ±9.93 1 .0 ±9.9
Albumin (g/L) 34.0–48.0 46.0 ±3.04 6 .0 ±3.0
Calcium (mmol/L) 2.1–2.5 2.3 ±0.12 .3 ±0.1
Creatinine (µmol/L) 44.2–106.1 79.6 ±17.77 9 .6 ±17.7
Magnesium (mmol/L) 0.7–1.1 0.9 ±0.04 0.9 ±0.04
Urine
Creatinine (mmol/L) 17.92 ±9.83 14.92 ±5.31
Calcium (mmol/L) 2.8 ±1.74 .1 ±2.4
Magnesium (mmol/L) 4.1 ±1.64 .3 ±1.9
Data are shown as number of participants (n)o rm e a n± SD.
Abbreviations: BMI: body mass index; 25(OH)D: 25-hydroxyvitamin D; PTH: parathyroid hormone.
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Figure 2: Mean serum 25(OH)D levels (a) and mean variation of serum 25(OH)D levels (b) were higher, after the intake of 50,000IU of
vitaminD3 with a high-fat meal (n = 15) when compared to a low-fat meal (n = 15). ∗P<0.001, comparing the two slopes. Data are shown
as mean and 95% conﬁdence interval.
The baseline characteristics are shown in Table 2. Photo-
types ranged from I to II. Serum 25(OH)D was <75nmol/L
in 28 subjects, <50nmol/L in 21 subjects, and <25nmol/L in
5subjects.Aftercholecalciferol,meanserum25(OH)Dlevels
and mean variation of serum 25(OH)D levels were higher in
G1 (P<0.001), and the diﬀerences were signiﬁcant at day 14
(Figures 2(a) and 2(b)).
At day 14, no one had hypercalcemia, and mean serum
total calcium (G1: 2.3 ± 0.1mmol/L and G2: 2.2 ±
0.1mmol/L; P = 0.11) and PTH (G1: 33.1 ± 11.0ng/L; G2:
36.4 ± 9.0ng/L, P = 0.37) were similar in both groups; the
mean change in serum PTH was negative in G1 (−1.8 ±
7.2ng/L) and positive (5.5 ± 7.1ng/L) in G2 (P<0.01).
In all participants, serum PTH and 25(OH)D levels were
negatively correlated at baseline and 14 days after the intake
of vitamin D, as shown in Figure 3.
4. Discussion
Theintakeof50,000IUofcholecalciferolwithafat-richmeal
increased mean serum 25(OH)D levels, in young adults. A
change in mean serum 25(OH)D levels was not observed in4 International Journal of Endocrinology
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Figure 3: Correlation between serum parathyroid hormone (PTH) and 25-hydroxyvitamin D [25(OH)D] levels, in young adults (n = 30),
at baseline (a), and 14 days after the oral intake of 50,000IU of vitamin D3 (b).
the group that received vitamin D along with low-fat food,
and its increase in the group that received the high-fat meal
was small. As a placebo group was not studied, it is possible
that serum 25(OH)D levels were decreasing in the sample
studied due to the season [18].
The improved bioavailability of cholecalciferol when
administered with fat-rich food could be due to a higher
release of bile, allowing an increased incorporation of fat in
the bile salt micelle, and its absorption [19]. Few studies have
evaluatedtheeﬀectofdietaryfatintheabsorptionofvitamin
D. In a clinical trial that compared the eﬀect of 25,000IU
of vitamin D2 intake with whole milk (8.4g of fat/serving),
skimmed milk (2.4g of fat/serving), or toast with 0.1mL of
corn oil, there was no diﬀerence in mean serum vitamin D2
levels, which suggested that its absorption is not dependent
on fat [9]. Nevertheless, the content of fat ingested was small
in all groups, so serum vitamin D levels could have been
higher if the vitamin had been ingested with more fat. In
another study, normal individuals consumed low-fat cheese
(∼3goffat/serving)orhigh-fatcheese(∼11goffat/serving),
fortiﬁed with 28,000IU of vitamin D, or the same amount of
vitamin D dissolved in ethanol, with or without food, per
w e e k ,f o r8w e e k s .M e a ns e r u m2 5 ( O H ) Dw e r es i m i l a ri na l l
groups treated with vitamin D and higher than placebo [14].
However, in these studies, the diﬀerence in the amount of
fat provided by the meals for diﬀerent groups was smaller
than the one in the present study, and the total amount of fat
oﬀered in the meals was also smaller. Moreover, dissolving
vitamin D in ethanol could have made its absorption easier.
In another study, higher mean serum vitamin D2 levels,
in young and older adults, were observed when the vitamin
was ingested with cheese (∼2 0go ff a t / s e r v i n g )w h e nc o m -
pared to water, suggesting that food facilitates its absorption,
and is not aﬀected by age [7]. In this study, the fat content of
cheese was similar to the one provided in our study. A recent
uncontrolled study found higher mean serum 25(OH)D
levels when vitamin D supplements were ingested during the
largest meal of the day; however, the content of these meals
was not described [20].
Although baseline mean serum 25(OH)D level was low
in all subjects and 5/30 subjects had serum 25(OH)D level
<25nmol/L, serum PTH levels were within the normal range
in all subjects. However, it is possible that at least part of the
subjects had secondary hyperparathyroidism, as there was
a negative correlation between serum PTH and 25(OH)D
levels [21]. It is known that serum PTH levels increase with
age,BMI,andlowserum25(OH)Dlevels[21,22].Thisstudy
was made in spring, when lower serum 25(OH)D levels are
expected in this region [18].
Our study has limitations. The absorption of vitamin D
was evaluated with only two meals with highly diﬀerent fat
content; however, these are not unusual dietary patterns in
everyday life. Moreover, as the two meals were diﬀerent also
in other components, to oﬀer a similar amount of calories,
it cannot be excluded that vitamin D3 absorption was
decreased in the low-fat meal group, due to its higher ﬁber
content. Also, it cannot be excluded that diﬀerent amounts
of vitamin D were ingested by the subjects, as the amount
of vitamin D in food was not evaluated. Nevertheless, it
is very improbable that dietary vitamin D inﬂuenced the
results, because natural food contains only small amounts
of vitamin D. In addition, the participants were advised
to keep their usual dietary patterns until completing the
study. Another limitation was the measurement of serum
25(OH)D levels as a surrogate for serum vitamin D levels.
Nonetheless, this metabolite increases rapidly after vitamin
D supplementation, and it is measured to evaluate vitamin D
status and the eﬀect of vitamin D supplementation [17, 23].
As vitamin D absorption could explain in part the
variability in serum 25(OH)D levels after the oral supple-
mentation of this vitamin, other studies should be designed
to clarify the role of food and dietary fat in vitamin D
absorption, allowing us to determine the most eﬀective way
to improve vitamin D nutrition.
In conclusion, the results of this small randomized
controlled trial show that vitamin D supplementation is
more eﬀective when given with fat-containing food. These
ﬁndings can have important implications to deﬁne the
adequate dietary intake of vitamin D.
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